It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
2-(2-Phenylethyl)chromones (PECs) are the principal constituents contributing to the distinctive fragrance of agarwood. How PECs are biosynthesized is currently unknown. In this work, we describe a diarylpentanoid-producing polyketide synthase (PECPS) identified from Aquilaria sinensis. Through biotransformation experiments using fluorine-labeled substrate, transient expression of PECPS in Nicotiana benthamiana, and knockdown of PECPS expression in A. sinensis calli, we demonstrate that the C6–C5–C6 scaffold of diarylpentanoid is the common precursor of PECs, and PECPS plays a crucial role in PECs biosynthesis. Crystal structure (1.98 Å) analyses and site-directed mutagenesis reveal that, due to its small active site cavity (247 Å3), PECPS employs a one-pot formation mechanism including a “diketide-CoA intermediate-released” step for the formation of the C6–C5–C6 scaffold. The identification of PECPS, the pivotal enzyme of PECs biosynthesis, provides insight into not only the feasibility of overproduction of pharmaceutically important PECs using metabolic engineering approaches, but also further exploration of how agarwood is formed.
2-(2-Phenylethyl)chromones (PECs) contribute to the distinctive fragrance of agarwood. Here the authors identify a diarylpentanoid-producing polyketide synthase from Aquilaria sinensis and show how it catalyzes PEC formation.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details







1 Beijing University of Chinese Medicine, Modern Research Center for Traditional Chinese Medicine, Beijing, People’s Republic of China (GRID:grid.24695.3c) (ISNI:0000 0001 1431 9176)
2 Beijing University of Chinese Medicine, Modern Research Center for Traditional Chinese Medicine, Beijing, People’s Republic of China (GRID:grid.24695.3c) (ISNI:0000 0001 1431 9176); Baotou Medical College, Baotou, People’s Republic of China (GRID:grid.410594.d) (ISNI:0000 0000 8991 6920)
3 University of Toyama, Institute of Natural Medicine, Toyama, Japan (GRID:grid.267346.2) (ISNI:0000 0001 2171 836X)
4 The University of Tokyo, Graduate School of Pharmaceutical Sciences, Tokyo, Japan (GRID:grid.26999.3d) (ISNI:0000 0001 2151 536X)
5 Beijing University of Chinese Medicine, Modern Research Center for Traditional Chinese Medicine, Beijing, People’s Republic of China (GRID:grid.24695.3c) (ISNI:0000 0001 1431 9176); China Academy of Chinese Medical Sciences, Institute of Chinese Materia Medica, Beijing, People’s Republic of China (GRID:grid.410318.f) (ISNI:0000 0004 0632 3409)
6 Beijing University of Chinese Medicine, Modern Research Center for Traditional Chinese Medicine, Beijing, People’s Republic of China (GRID:grid.24695.3c) (ISNI:0000 0001 1431 9176); School of Pharmaceutical Sciences, Peking University, State Key Laboratory of Natural and Biomimetic Drugs, Beijing, People’s Republic of China (GRID:grid.11135.37) (ISNI:0000 0001 2256 9319)